Clinical trial

Pepsinogens as the Early Marker of H. Pylori Eradication

NCT00197457 · Hamamatsu University, Other · Completed

Key facts

NCT number NCT00197457
Title Pepsinogens as the Early Marker of H. Pylori Eradication
Official title Serum Pepsinogens as an Early Diagnostic Marker of H. Pylori Eradication
Lead sponsor Hamamatsu University, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions H. Pylori Infection, Gastric Ulcer, Duodnal Ulcer
Intervention type Procedure
Interventions serum pepsinogen, urea breath test
Start date Jun 1, 2001
First posted Sep 20, 2005
Last update posted Feb 1, 2006
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies